Clinical Trial Details
EORTC-26981-22981
Back to Clinical Trials Database
"Concomitant and adjuvant Temozolomide and Radiotherapy for newly diagnosed glioblastoma multiforme. A randomized phase III study"
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 24-Jul-2000 Date Step1 close: 22-Mar-2002 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 520 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00006353 |
| NCT number | NCT00006353 |
